Home » Newsletters » BioWorld Science

BioWorld Science

June 22, 2016

View Archived Issues

Global Blood begins phase IIa study of GBT-440

National Cancer Institute studies LMB-100 for malignant mesothelioma

FDA grants fast track designation for ProTmune

EMA validates Santhera's MAA for Raxone in Duchenne muscular dystrophy

Immuron and WRAIR collaborate to develop Shigella vaccine

Curis doses the first patient in phase I trial of CA-170

FDA grants orphan drug designation for Wave Life Sciences' Huntington's disease candidate

Phase II trial of Frontier's AB-001 patch in chronic low back pain meets primary endpoint

Chugai and Maruho launch Marduox combination topical ointment for psoriasis vulgaris

AbbVie presents phase I results for ABT-165

Axon initiates phase II trial of AADvac-1 for Alzheimer's disease

Cancer Research Technology announces PARG inhibitors

Natco Pharma discloses antineoplastic agents

Pfizer introduces AMPK activators

TB Alliance and Takeda sign agreement to explore hits from TB screening program

Channel Therapeutics divulges imidazolyl-phenanthroline derivatives

Ferrer acquires Alexza Pharmaceuticals

RedHill Biopharma reports results from phase I study of Yeliva

Unique collaboration to translate stem cell discoveries into novel treatments for diabetes

GC-1118 shows antitumor activity in colorectal cancer

FDA grants fast track designation to Oncternal's TK-216

OctreoPharm Sciences diagnostic [68Ga]OPS-202 more sensitive than comparator in clinical trial

Japanese orphan drug designation for selexipag for chronic thromboembolic pulmonary hypertension

New GPR120 agonist shows promise for type 2 diabetes

GO-FURTHER data demonstrate golimumab improves hemoglobin levels and anemia

EnBiotix antibiotic-potentiator products EBX-001, EBX-002 show preclinical activity

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 9, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...